Orchard Capital Managment, LLC Ardelyx, Inc. Transaction History

Orchard Capital Managment, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.22 - $2.85 $1.8 Million - $4.21 Million	1,475,500 Added 103.8%	2,896,980 $8.26 Million
Q2 2022 Aug 15, 2022	BUY	$0.51 - $1.17 $18,921 - $43,407	37,100 Added 2.68%	1,421,480 $983,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $71,565 - $129,918	110,100 Added 8.64%	1,384,380 $1.48 Million
Q2 2021 Aug 17, 2021	BUY	$6.55 - $8.98 $306,638 - $420,398	46,815 Added 3.81%	1,274,280 $9.66 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $1.84 Million - $2.32 Million	301,125 Added 32.51%	1,227,465 $8.13 Million
Q4 2020 May 17, 2021	BUY	$5.05 - $7.1 $4.68 Million - $6.58 Million	926,340 New	926,340 $5.99 Million

214

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $854M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Orchard Capital Managment, LLC, based on Form 13F filings with the SEC.

Stay updated on Orchard Capital Managment, LLC with notifications on news.